• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜铬细胞瘤腹腔镜手术期间严重高血压的围手术期管理

Perioperative Management of Severe Hypertension during Laparoscopic Surgery for Pheochromocytoma.

作者信息

Erdoğan Mehmet Ali, Uçar Muharrem, Özkan Ahmet Selim, Özgül Ülkü, Durmuş Mahmut

机构信息

Department of Anaesthesiology and Reanimation, İnönü University School of Medicine, Turgut Özal Medical Center, Malatya, Turkey.

出版信息

Turk J Anaesthesiol Reanim. 2016 Feb;44(1):47-9. doi: 10.5152/TJAR.2016.25993. Epub 2016 Feb 1.

DOI:10.5152/TJAR.2016.25993
PMID:27366556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4894119/
Abstract

Phaeochromocytoma is a catecholamine-secreting vascular tumour that is derived from chromaffin cell. Lethal cardiovascular complications, such as serious hypertension, myocardial infarction and aortic dissection, may occur because of uncontrolled catecholamine release. Each stage of anaesthesia management has vital importance because of this destructive catecholamine secretion that may occur during induction, perioperative stage and surgical manipulation. In this study, we report regarding the preoperative preparation and severe, persistent hypertension attack management with a combination of α-adrenergic blockade, β-adrenergic blockade, sodium nitroprusside and remifentanil in a patient who underwent laparoscopic surgery for phaeochromocytoma.

摘要

嗜铬细胞瘤是一种分泌儿茶酚胺的血管肿瘤,起源于嗜铬细胞。由于儿茶酚胺释放不受控制,可能会发生致命的心血管并发症,如严重高血压、心肌梗死和主动脉夹层。由于在诱导期、围手术期和手术操作过程中可能会出现这种具有破坏性的儿茶酚胺分泌,麻醉管理的每个阶段都至关重要。在本研究中,我们报告了一名接受腹腔镜嗜铬细胞瘤手术患者的术前准备以及联合使用α-肾上腺素能阻滞剂、β-肾上腺素能阻滞剂、硝普钠和瑞芬太尼治疗严重持续性高血压发作的情况。

相似文献

1
Perioperative Management of Severe Hypertension during Laparoscopic Surgery for Pheochromocytoma.嗜铬细胞瘤腹腔镜手术期间严重高血压的围手术期管理
Turk J Anaesthesiol Reanim. 2016 Feb;44(1):47-9. doi: 10.5152/TJAR.2016.25993. Epub 2016 Feb 1.
2
Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.围手术期α1受体阻滞剂对嗜铬细胞瘤腹腔镜手术期间血流动力学控制的影响。
Br J Anaesth. 2004 Apr;92(4):512-7. doi: 10.1093/bja/aeh083. Epub 2004 Feb 6.
3
[Anaesthesia for patients with phaeochromocytoma - specifics, potential complications and drug strategies].[嗜铬细胞瘤患者的麻醉——特点、潜在并发症及药物策略]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2008 Jan;43(1):20-7; quiz 28. doi: 10.1055/s-2008-1038087.
4
[Anesthesia for patients with pheochromocytoma. Our own results and a review].[嗜铬细胞瘤患者的麻醉。我们自己的结果及综述]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1993 Dec;28(8):500-9. doi: 10.1055/s-2007-998971.
5
Anaesthetic management of giant phaeochromocytoma in a patient with chronic renal disease.一名慢性肾病患者巨大嗜铬细胞瘤的麻醉管理
J West Afr Coll Surg. 2011 Apr;1(2):112-22.
6
Phaeochromocytoma--views on current management.嗜铬细胞瘤——当前治疗观点
Eur J Surg Oncol. 2003 Aug;29(6):483-90. doi: 10.1016/s0748-7983(03)00071-4.
7
Laparoscopic Surgery for Pheochromocytoma and Paraganglioma Removal: A Retrospective Analysis of Anaesthetic Management.腹腔镜手术切除嗜铬细胞瘤和副神经节瘤:麻醉管理的回顾性分析
Curr Hypertens Rev. 2016;12(3):222-227. doi: 10.2174/1573402112666160510122357.
8
Perioperative management of phaeochromocytoma.嗜铬细胞瘤的围手术期管理
Acta Anaesthesiol Belg. 2009;60(1):55-66.
9
Remifentanil in the management of laparoscopic resection of phaeochromocytoma--case reports.瑞芬太尼用于嗜铬细胞瘤腹腔镜切除术的管理——病例报告
Ann Acad Med Singap. 2003 Nov;32(6):828-31.
10
[Intraoperative diagnosis of a multilocal pheochromocytoma].[多灶性嗜铬细胞瘤的术中诊断]
Anaesthesist. 1997 Sep;46(9):783-6. doi: 10.1007/s001010050469.

引用本文的文献

1
The effects of perioperative dexmedetomidine infusion on hemodynamic stability during laparoscopic adrenalectomy for pheochromocytoma: a randomized study.围手术期输注右美托咪定对嗜铬细胞瘤腹腔镜肾上腺切除术期间血流动力学稳定性的影响:一项随机研究。
Front Med (Lausanne). 2023 Nov 2;10:1276535. doi: 10.3389/fmed.2023.1276535. eCollection 2023.
2
Preoperative selective vs non-selective α-blockade in PPGL patients undergoing adrenalectomy.嗜铬细胞瘤/副神经节瘤患者肾上腺切除术术前选择性与非选择性α受体阻滞
Endocr Connect. 2017 Nov;6(8):830-838. doi: 10.1530/EC-17-0232. Epub 2017 Oct 6.

本文引用的文献

1
Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin.围手术期嗜铬细胞瘤的处理:关注镁、考来维仑和血管加压素。
J Cardiothorac Vasc Anesth. 2012 Jun;26(3):526-31. doi: 10.1053/j.jvca.2012.01.002. Epub 2012 Feb 22.
2
Anesthesia and pheochromocytoma.麻醉与嗜铬细胞瘤
Int Anesthesiol Clin. 2011 Spring;49(2):57-61. doi: 10.1097/AIA.0b013e3181ff4db0.
3
Preoperative management of the pheochromocytoma patient.嗜铬细胞瘤患者的术前管理。
J Clin Endocrinol Metab. 2007 Nov;92(11):4069-79. doi: 10.1210/jc.2007-1720.
4
Can a patient be successfully prepared for pheochromocytoma surgery in three days? A case report.患者能否在三天内成功做好嗜铬细胞瘤手术的准备?一例病例报告。
Minerva Anestesiol. 2007 Apr;73(4):245-8.
5
The perioperative management of a patient with complex single ventricle physiology and pheochromocytoma.复杂单心室生理合并嗜铬细胞瘤患者的围手术期管理
Anesth Analg. 2005 Apr;100(4):972-975. doi: 10.1213/01.ANE.0000146433.84742.3A.
6
Laparoscopic adrenalectomy for pheochromocytoma: comparison with conventional open adrenalectomy.腹腔镜下嗜铬细胞瘤肾上腺切除术:与传统开放性肾上腺切除术的比较
J Endourol. 2004 Apr;18(3):251-5. doi: 10.1089/089277904773582859.
7
Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma.围手术期α1受体阻滞剂对嗜铬细胞瘤腹腔镜手术期间血流动力学控制的影响。
Br J Anaesth. 2004 Apr;92(4):512-7. doi: 10.1093/bja/aeh083. Epub 2004 Feb 6.
8
The use of remifentanil in the anaesthetic management of patients undergoing adrenalectomy: a report of three cases.瑞芬太尼在肾上腺切除术患者麻醉管理中的应用:三例报告
Anaesthesia. 2003 Apr;58(4):358-62. doi: 10.1046/j.1365-2044.2003.03080.x.
9
Exclusive use of calcium channel blockers in preoperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients.钙通道阻滞剂在嗜铬细胞瘤术前及术中控制中的单独应用:连续10例患者的血流动力学及游离儿茶酚胺检测
Surgery. 1989 Dec;106(6):1149-54.